Two Indian surgeons honoured at International Conference of Oral and Maxillofacial Surgery thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
5-year old Master Samaksh Jain hailing from Rajasthan has a developmental condition called ED (Ectodermal Dysplasia). He has no teeth in the lower jaw & just two teeth in the upper jaw.
New Delhi [India], March 8 (ANI/SRV): Zoriox Innovation Labs is a medical device company with a young and dynamic team founded by Dr Karthik Balaji, Krishna Chaitanya Gurijala, and Krishna Vaka Reddy along with the Advisory Mentorship of Suyamburam Sathasivam (Vice President of Sun Pharmaceutical Industries Limited) of Indian origin who has been collectively working with the breakthrough technology in Patient-Specific Implants (PSI) along with facial surgeons for the reconstruction of the face.
Get latest articles and stories on Business at LatestLY. Zoriox Innovation Labs is a medical device company with a young and dynamic team founded by Dr Karthik Balaji, Krishna Chaitanya Gurijala, and Krishna Vaka Reddy along with the Advisory Mentorship of Suyamburam Sathasivam (Vice President of Sun Pharmaceutical Industries Limited) of Indian origin who has been collectively working with the breakthrough technology in Patient-Specific Implants (PSI) along with facial surgeons for the reconstruction of the face. Business News | Surgeons in India Create Marvels in Facial Reconstruction Using 3D Printing Technology.
Updated: Mar 5, 2021, 09:09 PM IST
An eight-month-long study to determine the feasibility of the Saliva-based Covid-19 Rapid Antigen Test (RAT) has revealed that the test is less expensive, faster and safer than the RT-PCR tests which are widely used in India. While saliva-based RAT is approved by the Food and Drug Administration (FDA) in the US, this test is not approved by the Indian Council of Medical Research (ICMR). However, nasal and oral RAT is permitted in India.
According to the doctors, this study was done to establish the efficacy of the test among the Indian population, as not many studies were performed in India on this method of saliva-based testing.
Highlights
According to the Doctors, this study was done to establish the efficacy of the test among the Indian population, as not many studies were performed in India on this method of saliva-based testing.
Chennai: An eight month long study to determine the feasibility of the Saliva-based COVID-19 Rapid Antigen Test (RAT) has revealed that the test is less expensive, faster and safer than the RT-PCR tests which are widely used in India. While saliva-based RAT are approved by the Food and Drug Administration (FDA) in the US, this test is not approved by the Indian Council of Medical Research (ICMR). However, the nasal and oral RAT are permitted in India.
Results conform to ICMR norms Saliva-based rapid antigen test (RAT) could be effective, faster and economical in the diagnosis of COVID-19, a study has found.
Chennai Dental Research Foundation (CDRF), Voluntary Health Services (VHS) and Ragas Dental College and Hospital conducted the study. The results achieved the minimum standards set by the Indian Council of Medical Research (ICMR). It recorded a sensitivity of 56% as against the 50% required by ICMR and specificity of 100%, compared with 95% set by ICMR, according to a release.
Gunaseelan Rajan, president of CDRF, said the biggest advantage of RAT was that it was faster than RT-PCR test. “It is safe. One can take up a self-test at home or office. Our research has shown that using saliva for RAT was rapid and effective. It could be utilised for mass screening, rapid screening, and by dentists and ENT doctors as it can detect the virus in 10 minutes,” he said. He said they had written about the findings to the Centre, while the results were accepted for publication in an international journal “Oral Diseases” in February 2021.